MicroA

MicroA is a Norwegian biotechnology company specializing in the production of high-value compounds from microalgae using proprietary cultivation technology. The company has developed a patented, closed photobioreactor system that enables the sterile and highly controlled production of microalgae, ensuring superior purity and quality compared to traditional open-pond methods. Its flagship product is natural astaxanthin, a powerful antioxidant derived from the microalgae Haematococcus pluvialis, which is supplied to the global nutraceutical and pharmaceutical industries. Beyond astaxanthin, MicroA is exploring the production of other bioactive molecules and specialty ingredients for applications in animal health and human nutrition. In 2021, the company entered into a strategic partnership with Aker BioMarine to accelerate the commercialization and distribution of its algae-based products.